drugset / Trial / NCT02014740
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this research study is to learn about the effect of Liraglutide, (Victoza®), on the fat surrounding the heart.Excessive amount of the fat around the heart is common in people with type 2 diabetes and can be associated with poor sugar control. Liraglutide is an injectable prescription medicine that can improve blood sugar control in adults with type 2 diabetes.
Timeline
- Start
- 2014-03
- Primary completion
- 2017-03
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 1.8 mg | Subcutaneous |
| Background | Metformin | Small molecule | 1000 mg | — |